SATHISH DYAWANAPELLY | Pharmacology and Drug Development | Young Scientist Award

Published on by Life Science

Young Scientist Award

SATHISH DYAWANAPELLY
Affiliation Institute of Chemical Technology (ICT), Mumbai
Country India
Scopus ID 56293760300
Documents 39
Citations 1947
h-index 24
Subject Area Pharmacology and Drug Development
Event World Life Science Awards

SATHISH DYAWANAPELLY is a researcher associated with the Institute of Chemical Technology (ICT), Mumbai, whose scholarly work has focused on pharmacology, nanomedicine, drug delivery systems, biomaterials, and pharmaceutical innovation. His research portfolio demonstrates sustained contributions to the advancement of drug development methodologies, polymer therapeutics, pulmonary delivery systems, nanovaccines, and translational pharmaceutical sciences. The combination of publication output, citation performance, and interdisciplinary research engagement provides a basis for consideration within academic recognition programs such as the Young Scientist Award.[1]

Abstract

This article presents an academic overview of SATHISH DYAWANAPELLY and evaluates his suitability for recognition through the Young Scientist Award. The assessment is based on publicly available scholarly indicators including publication productivity, citation performance, research specialization, and documented contributions to pharmaceutical sciences and drug delivery technologies. His work spans nanomedicine, cancer therapeutics, pulmonary formulations, biomimetic nanovaccines, and advanced pharmaceutical engineering, demonstrating interdisciplinary engagement within life science research.[1][2]

Keywords

Nanomedicine, Drug Delivery Systems, Pharmacology, Polymer Therapeutics, Pulmonary Drug Delivery, Pharmaceutical Sciences, Cancer Therapy, Biomaterials, Nanovaccines, Life Sciences.

Introduction

The development of modern therapeutics increasingly relies on innovative drug delivery technologies capable of improving efficacy, safety, and patient outcomes. Researchers working at the intersection of pharmaceutical sciences and nanotechnology contribute substantially to this objective. SATHISH DYAWANAPELLY has developed a research profile centered on advanced delivery systems, polymer-based therapeutics, and translational pharmaceutical technologies, contributing to emerging areas of life science research.[2][3]

Research Profile

Based at the Institute of Chemical Technology (ICT), Mumbai, SATHISH DYAWANAPELLY has established a scholarly record characterized by publications in internationally recognized journals and interdisciplinary collaborations. His Scopus metrics indicate 39 indexed documents, 1,947 citations, and an h-index of 24, reflecting measurable research visibility and influence within pharmacology and drug development.[1]

  • Specialization in pharmacology and advanced drug delivery systems.
  • Research involvement in nanomedicine and biomaterial-based therapeutics.

Research Contributions

The research contributions of SATHISH DYAWANAPELLY encompass several areas of pharmaceutical innovation. His studies have explored polymer therapeutics, pulmonary drug delivery systems, nanoparticle engineering, biomimetic nanovaccines, and cancer-targeted delivery technologies. These investigations address practical challenges associated with therapeutic effectiveness, bioavailability, and targeted treatment strategies.[2]

  • Polymer therapeutics and pharmacokinetic optimization.
  • Nanovaccine development and biomimetic delivery technologies.
  • Pulmonary drug delivery approaches for chronic diseases.

Publications

Selected publications associated with SATHISH DYAWANAPELLY demonstrate engagement with contemporary pharmaceutical research topics and high-impact translational applications.[2]

  1. The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Biodistribution.
  2. Understanding the Nano-Bio Interactions Using Real-Time Surface Plasmon Resonance Tool.
  3. Multifaceted Therapeutic Applications of Biomimetic Nanovaccines.

Research Impact

Citation metrics, publication quality, and subject relevance collectively indicate that the research activities of SATHISH DYAWANAPELLY have generated measurable scholarly attention. The citation count of 1,947 and h-index of 24 suggest that multiple publications have influenced subsequent investigations within pharmaceutical sciences and drug delivery research. Such indicators are commonly considered when evaluating research significance and scientific visibility.[1]

Award Suitability

The Young Scientist Award recognizes emerging and accomplished researchers who demonstrate innovation, scientific productivity, and meaningful contributions within their disciplines. Based on available scholarly indicators, SATHISH DYAWANAPELLY exhibits characteristics aligned with such recognition, including interdisciplinary research output, citation impact, active publication record, and contributions to pharmaceutical innovation. His work on advanced therapeutic delivery technologies aligns with contemporary priorities in life science and healthcare research.[1][2]

Conclusion

SATHISH DYAWANAPELLY has developed a notable academic profile within pharmacology and drug development through contributions to nanomedicine, drug delivery systems, biomaterials, and therapeutic innovation. The combination of publication productivity, citation performance, and interdisciplinary research engagement supports consideration for academic recognition programs such as the Young Scientist Award under the World Life Science Awards framework.[1]

References

  1. Sampathi, S., Tiriya, P. K., Dodoala, S., Junnuthula, V., & Dyawanapelly, S. (2022). Development of biocompatible ciprofloxacin–gold nanoparticle coated sutures for surgical site infections. Pharmaceutics, 14(10), Article 2130.
    https://doi.org/10.3390/pharmaceutics14102130
  2. Parihar, A., Prajapati, B. G., Paliwal, H., Shukla, M., Khunt, D., Bahadure, S. D., Dyawanapelly, S., & Junnuthula, V. (2023). Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis. Drug Discovery Today, 28(10), Article 103729
    https://doi.org/10.1016/j.drudis.2023.103729
  3. Iyer, G., Dyawanapelly, S., Jain, R., & Dandekar, P. (2022). An overview of oral insulin delivery strategies (OIDS).
    https://doi.org/10.1016/j.ijbiomac.2022.03.144

Yasser Alraey | Infectious Diseases | Best Researcher Award

Published on by Life Science

Dr. Yasser Alraey | Infectious Diseases | Best Researcher Award

king Khalid university | Saudi Arabia

Dr. Yasser Alraey is a distinguished senior microbiologist and assistant professor of tropical medicine with over 16 years of laboratory‐based and academic experience. He has developed deep expertise in molecular diagnostics, vector-borne diseases, metagenomics, epidemiology, parasites and vectors, quality management, and lab leadership. His roles have spanned from medical lab technologist to head of flow cytometry and histopathology labs, through to his current clinical duties and academic leadership at King Khalid University and in senior specialist laboratory roles in Abha. Holding a PhD from the Liverpool School of Tropical Medicine, along with MSc and BSc qualifications, he also earned a Clinical Laboratory Leadership & Management Certificate from AACC. Dr. Alraey has supervised and taught extensively, contributed to departmental administration, and managed multiple research projects including work on cutaneous leishmaniasis, molecular detection in stray animals, COVID-19 diagnostics, and antimicrobial resistance. He has published a substantial body of work in peer-reviewed journals, Include Scopus with 37 documents and 467 citations to his name, giving him an h-index of 12, reflecting his wide impact in tropical medicine and molecular microbiology. He is a motivational leader, methodical multitasker, and an inspiring communicator committed to high quality in laboratory services and education.

Featured Publications

Alraey, Y., Alshahrani, A., Alshahrani, T. S. M., Al Draim, N. H. A., Sumayli, A. A., Mana, A. M., Alqahtani, A. A., AlAbdullah, M. S., Mjrashi, A. M., Alqhtani, S. J., et al. (2025). Unveiling risk factors and sandfly ecology in cutaneous leishmaniasis-endemic areas of the Asir Region, Saudi Arabia. Journal of Infection and Public Health. Advance online publication.

Bharadava, K., Upadhyay, T. K., Kaushal, R. S., Ahmad, I., Alraey, Y., Siddiqui, S., & Saeed, M. (2024). Genomic insight of Leishmania parasite: In-depth review of drug resistance mechanisms and genetic mutations. ACS Omega, 9(1), Article e3C09400.

Al Shahrani, M., Gahtani, R., Abohassan, M., Alshahrani, M., Alraey, Y., Dera, A., Asiri, M. R., & Rajagopalan, P. (2024). High-throughput computational screening and in vitro evaluation identifies 5-(4-oxo-4H-3,1-benzoxazin-2-yl)-2-[3-(4-oxo-4H-3,1-benzoxazin-2-yl) phenyl]-1H-isoindole-1,3(2H)-dione (C3), as a novel EGFR-HER2 dual inhibitor in gastric tumors. Oncology Research, 32(1), Article 043139.

Siddique, S., Chaudhry, M. N., Ahmad, S. R., Nazir, R., Javed, R., Hafeez, M. R., Alraey, Y., Sivasamugham, L. A., & Mahmood, A. (2024). Risk surveillance with spatial distribution of organochlorine pesticides (OCPs) from sedimentary samples of Chenab River. Science of the Total Environment, 924, 169256. x

Bajwa, A., Sadef, Y., Nazir, R., Zaheer, M., Siddique, S., Alismail, H. A., Sivasamugham, L. A., & Mahmood, A. (2024, December). Integrated risk assessment and human health hazards via dietary intake of OCPs from cereal crops cultivated across river Chenab. Emerging Contaminants.

Pratap Mali | Drug Development | Best Researcher Award

Published on by Life Science

Prof. Pratap Mali | Drug Development | Best Researcher Award

University of Rajasthan, Jaipur | India

Dr. Pratap Chand Mali is a Professor in the Department of Zoology, University of Rajasthan, Jaipur, specializing in reproductive biology and physiology with a strong research focus on antifertility effects of medicinal plants and natural products. His academic profile is supported by a notable citation record, with 636 citations, an h-index of 12, and an i10-index of 16, reflecting his scholarly contributions and impact in the field. Over the years, he has authored numerous scientific documents and research articles, many of which explore innovative strategies for fertility regulation, contraceptive development, and reproductive health using phytochemicals and natural extracts. His publications span international journals, conferences, and symposiums, indicating both national and global engagement in advancing reproductive bioscience. In addition to his research, Prof. Mali has played significant editorial roles across multiple reputed journals and has been an invited speaker at high-profile scientific conferences worldwide. His research portfolio demonstrates a consistent dedication to addressing reproductive health challenges while exploring safe, effective, and reversible contraceptive methods. With his substantial output of academic documents, coupled with steady citation growth, Prof. Mali continues to influence the domains of reproductive biology, contraceptive innovation, and natural product pharmacology.

Profiles: Orcid | Scopus

Featured Publication

Targeting IDO1 in Huntington’s Disease: Network Pharmacology and Preclinical Evidence from Coffea arabica